Literature DB >> 17289839

Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates.

Jun Yang1, Hongtao Chen, Iontcho R Vlahov, Ji-Xin Cheng, Philip S Low.   

Abstract

Despite the widely accepted assumption that most endosomal compartments are acidic, evaluation of the efficiency of pH-dependent drug release from a ligand-targeted drug conjugate during receptor-mediated endocytosis is lacking. Therefore, we have characterized the kinetics of pH-dependent drug release from a model folate-drug conjugate during folate receptor (FR)-mediated endosomal trafficking. For this purpose, we synthesized an acid-labile folate-fluorescence resonance energy transfer reporter (ALFR) that emits green fluorescence (BODIPY FL, 6-((4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diazas-indacene-3-propionyl)amino)hexanoic acid) only after acid-catalyzed hydrolysis of the acyl hydrazone linker. In a cell-free system, cleavage of ALFR was found to be efficient only at acidic pH values (t1/2=1.95, 4.63, and 75 h at pH 4, 5, and 6, respectively) and essentially resistant to hydrolysis at pH 7. Curiously, when applied to folate receptor-expressing cancer cells, the acid-labile folate-linked probe exhibited little or no recovery of BODIPY FL fluorescence (green), even after 55 h of incubation, arguing very inefficient cleavage within the FR endocytic pathway. To understand this unanticipated observation, we measured the pH of FR-containing endosomes using ratiometric fluorescence microscopy and observed that most FR+ endosomes are only mildly acidic (average approximately pH 6.5). Taken together, these data argue that the FR-trafficking pathway does not involve acidic compartments and that acyl hydrazone linkers may constitute a poor option for FR-mediated drug delivery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289839     DOI: 10.1124/jpet.106.117648

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  28 in total

1.  Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.

Authors:  Ming-Hsin Li; Seok Ki Choi; Thommey P Thomas; Ankur Desai; Kyung-Hoon Lee; Alina Kotlyar; Mark M Banaszak Holl; James R Baker
Journal:  Eur J Med Chem       Date:  2011-11-23       Impact factor: 6.514

2.  Brief report novel mechanism for valproate-induced teratogenicity.

Authors:  Kristin Fathe; Ana Palacios; Richard H Finnell
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-07-26

3.  Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors.

Authors:  Xin Wei; Thulani H Senanayake; Galya Warren; Serguei V Vinogradov
Journal:  Bioconjug Chem       Date:  2013-04-02       Impact factor: 4.774

Review 4.  pH-Responsive nanoparticles for drug delivery.

Authors:  Weiwei Gao; Juliana M Chan; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2010-10-27       Impact factor: 4.939

Review 5.  Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.

Authors:  Rongbao Zhao; Larry H Matherly; I David Goldman
Journal:  Expert Rev Mol Med       Date:  2009-01-28       Impact factor: 5.600

6.  A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis.

Authors:  Rongbao Zhao; Sang Hee Min; Yanhua Wang; Estela Campanella; Philip S Low; I David Goldman
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

7.  Cholesterol level regulates endosome motility via Rab proteins.

Authors:  Hongtao Chen; Jun Yang; Philip S Low; Ji-Xin Cheng
Journal:  Biophys J       Date:  2007-11-02       Impact factor: 4.033

8.  Intracellular delivery and trafficking dynamics of a lymphoma-targeting antibody-polymer conjugate.

Authors:  Geoffrey Y Berguig; Anthony J Convertine; Julie Shi; Maria Corinna Palanca-Wessels; Craig L Duvall; Suzie H Pun; Oliver W Press; Patrick S Stayton
Journal:  Mol Pharm       Date:  2012-11-05       Impact factor: 4.939

Review 9.  Use of liposomes as drug delivery vehicles for treatment of melanoma.

Authors:  Melissa A Tran; Rebecca J Watts; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2009-05-22       Impact factor: 4.693

10.  The functional roles of the His247 and His281 residues in folate and proton translocation mediated by the human proton-coupled folate transporter SLC46A1.

Authors:  Ersin Selcuk Unal; Rongbao Zhao; Min-Hwang Chang; Andras Fiser; Michael F Romero; I David Goldman
Journal:  J Biol Chem       Date:  2009-04-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.